Evidence map›Paper›PMID 36923151›Full record

ArticleFrontiers in psychology2023

The Conners Continuous Performance Test CPT3

Judith Fernández-Quirós, Marcos Lacasa-Cazcarra, Jose Alegre-Martín, Ramón Sanmartín-Sentañes, Miriam Almirall, Patricia Launois-Obregón, Jesús Castro-Marrero, Amanda Rodríguez-Urrutia, Jose A Navarro-Sanchis, J Antoni Ramos-Quiroga

Open access · goldFull text read
In one paragraph

Article in Frontiers in psychology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Judith Fernández-QuirósMyalgic Encephalomyelitis/Chronic Fatigue Syndrome Unit, Division of Rheumatology, Vall d'Hebron Hospital Research Institute Universitat Autònoma de Barcelona, Barcelona, Spain.
Marcos Lacasa-Cazcarrae-Health Center, Universitat Oberta de Catalunya, Barcelona, Spain.
Jose Alegre-MartínMyalgic Encephalomyelitis/Chronic Fatigue Syndrome Unit, Division of Rheumatology, Vall d'Hebron Hospital Research Institute Universitat Autònoma de Barcelona, Barcelona, Spain.
Ramón Sanmartín-SentañesMyalgic Encephalomyelitis/Chronic Fatigue Syndrome Unit, Division of Rheumatology, Vall d'Hebron Hospital Research Institute Universitat Autònoma de Barcelona, Barcelona, Spain.
Miriam AlmirallMyalgic Encephalomyelitis/Chronic Fatigue Syndrome Unit, Division of Rheumatology, Vall d'Hebron Hospital Research Institute Universitat Autònoma de Barcelona, Barcelona, Spain.
Patricia Launois-ObregónMyalgic Encephalomyelitis/Chronic Fatigue Syndrome Unit, Division of Rheumatology, Vall d'Hebron Hospital Research Institute Universitat Autònoma de Barcelona, Barcelona, Spain.
Jesús Castro-MarreroMyalgic Encephalomyelitis/Chronic Fatigue Syndrome Unit, Division of Rheumatology, Vall d'Hebron Hospital Research Institute Universitat Autònoma de Barcelona, Barcelona, Spain.
Amanda Rodríguez-UrrutiaDepartment of Mental Health, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Jose A Navarro-SanchisDepartment of Mental Health, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
J Antoni Ramos-QuirogaDepartment of Mental Health, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Universitat Autònoma de Barcelona · ESVall d'Hebron Hospital Universitari · ESVall d'Hebron Institut de Recerca · ESUniversitat Oberta de Catalunya · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The main objective is to delimit the cognitive dysfunction associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in adult patients by applying the Continuous Performance Test (CPT3 Method: The final sample ( Results: There were significant differences between ME/CFS and healthy controls in all the main measures of CPT3 Conclusion: The CPT3

Indexed as

Central Sensitization Syndromeschronic fatigue syndromecognitive impairmentscontinuous performance testCPT3™neurocognitive dysfunctionneuropsychological test

Identifiers

PMID36923151
PMCPMC10008938
OpenAlexW4322504027

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read2
measurements read13
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.